The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
MUC1 and HIF-1alpha Signaling Crosstalk Induces Anabolic Glucose Metabolism to Impart Gemcitabine Resistance to Pancreatic Cancer
Open accessAbstract
SUMMARY Poor response to cancer therapy due to resistance remains a clinical challenge. The present study establishes a widely prevalent mechanism of resistance to gemcitabine in pancreatic cancer, whereby increased glycolytic flux leads to glucose addiction in cancer cells and a corresponding increase in pyrimidine biosynthesis to enhance the intrinsic levels of deoxycytidine triphosphate (dCTP). Increased levels of dCTP diminish the effective levels of gemcitabine through molecular competition. We also demonstrate that MUC1-regulated stabilization of HIF-1α mediates such metabolic reprogramming. Targeting HIF-1a or de novo pyrimidine biosynthesis, in combination with gemcitabine, strongly diminishes tumor burden. Finally, reduced expression of TKT and CTPS, which regulate flux into pyrimidine biosynthesis, correlates with better prognosis in pancreatic cancer patients on fluoropyrimidine analogs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Zhang, H., Wong, C. C. L., Wei, H., Gilkes, D. M., Korangath, P., Chaturvedi, P., Schito, L., Chen, J., Krishnamachary, B., Winnard, P. T., et al. (2012) · Oncogene · doi:10.1038/onc.2011.365 · Cited by 326
RetractedHallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Analyzing real-time PCR data by the comparative CT method
Schmittgen, T. D., & Livak, K. J. (2008) · Nature Protocols · doi:10.1038/nprot.2008.73 · Cited by 26,190
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Self-citationFOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Conroy, T., Desseigne, F., Ychou, M., Bouché, O., Guimbaud, R., Bécouarn, Y., Adenis, A., Raoul, J.-L., Gourgou-Bourgade, S., de la Fouchardière, C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1011923 · Cited by 7,810
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717 · cited 1×
“The hypoxic microenvironment of pancreatic tumors stabilizes HIF-1a, which is themaster regulator of glucosemetabolism and induces glucose dependence in cancer cells (Semenza, 2003, 2009).”
BackgroundIncreased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Von Hoff, D. D., Ervin, T., Arena, F. P., Chiorean, E. G., Infante, J., Moore, M., Seay, T., Tjulandin, S. A., Ma, W. W., Saleh, M. N., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1304369 · Cited by 6,712
The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088
HMDB 3.0—The Human Metabolome Database in 2013
Wishart, D. S., Jewison, T., Guo, A. C., Wilson, M., Knox, C., Liu, Y., Djoumbou, Y., Mandal, R., Aziat, F., Dong, E., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1065 · Cited by 2,845
Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism
Ying, H., Kimmelman, A. C., Lyssiotis, C. A., Hua, S., Chu, G. C., Fletcher-Sananikone, E., Locasale, J. W., Son, J., Zhang, H., Coloff, J. L., et al. (2012) · Cell · doi:10.1016/j.cell.2012.01.058 · Cited by 2,043
Self-citationDefining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
Semenza, G. L. (2010) · Oncogene · doi:10.1038/onc.2009.441 · Cited by 1,712 · cited 1×
“Both desmoplasia and hypoxia also lead to the stabilization of hypoxia inducible factor-1a (HIF-1a), the master regulator of glucose metabolism (Semenza, 2010).”
BackgroundUsing MetaboAnalyst 3.0 for Comprehensive Metabolomics Data Analysis
Xia, J., & Wishart, D. S. (2016) · Current Protocols in Bioinformatics · doi:10.1002/cpbi.11 · Cited by 1,544
HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations
Semenza, G. L. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67230 · Cited by 1,335
Yuan, M., Breitkopf, S. B., Yang, X., & Asara, J. M. (2012) · Nature Protocols · doi:10.1038/nprot.2012.024 · Cited by 1,117
Self-citationRegulation of Oxygen Homeostasis by Hypoxia-Inducible Factor 1
Semenza, G. L. (2009) · Physiology · doi:10.1152/physiol.00045.2008 · Cited by 926
Wu, M., Neilson, A., Swift, A. L., Moran, R., Tamagnine, J., Parslow, D., Armistead, S., Lemire, K., Orrell, J., Teich, J., et al. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00247.2006 · Cited by 918
Pancreatic tumors show high levels of hypoxia
Koong, A. C., Mehta, V. K., Le, Q. T., Fisher, G. A., Terris, D. J., Brown, J. M., Bastidas, A. J., & Vierra, M. (2000) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(00)00803-8 · Cited by 650
Metabolite identification via the Madison Metabolomics Consortium Database
Cui, Q., Lewis, I. A., Hegeman, A. D., Anderson, M. E., Li, J., Schulte, C. F., Westler, W. M., Eghbalnia, H. R., Sussman, M. R., & Markley, J. L. (2008) · Nature Biotechnology · doi:10.1038/nbt0208-162 · Cited by 632
Digoxin and other cardiac glycosides inhibit HIF-1α synthesis and block tumor growth
Zhang, H., Qian, D. Z., Tan, Y. S., Lee, K., Gao, P., Ren, Y. R., Rey, S., Hammers, H., Chang, D., Pili, R., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809763105 · Cited by 624 · cited 3×
“HIF-1a binding was further induced under hypoxic conditions and diminished by digoxin, a translational inhibitor of HIF-1a (Zhang et al., 2008).”
Backgroundde Sousa Cavalcante, L., & Monteiro, G. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.07.041 · Cited by 576
Pyruvate carboxylase is required for glutamine-independent growth of tumor cells
Cheng, T., Sudderth, J., Yang, C., Mullen, A. R., Jin, E. S., Matés, J. M., & DeBerardinis, R. J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1016627108 · Cited by 475
Self-citationGeneration of orthotopic and heterotopic human pancreatic cancer xenografts in immunodeficient mice
Kim, M. P., Evans, D. B., Wang, H., Abbruzzese, J. L., Fleming, J. B., & Gallick, G. E. (2009) · Nature Protocols · doi:10.1038/nprot.2009.171 · Cited by 380
Self-citationRethinking the Warburg Effect with Myc Micromanaging Glutamine Metabolism
Dang, C. V. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3556 · Cited by 379
Weizman, N., Krelin, Y., Shabtay-Orbach, A., Amit, M., Binenbaum, Y., Wong, R. J., & Gil, Z. (2014) · Oncogene · doi:10.1038/onc.2013.357 · Cited by 281
Rückemann, K., Fairbanks, L. D., Carrey, E. A., Hawrylowicz, C. M., Richards, D. F., Kirschbaum, B., & Simmonds, H. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.34.21682 · Cited by 270
Song, X., Liu, X., Chi, W., Liu, Y., Wei, L., Wang, X., & Yu, J. (2006) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-006-0224-7 · Cited by 258
Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia
Shukla, S. K., Gebregiworgis, T., Purohit, V., Chaika, N. V., Gunda, V., Radhakrishnan, P., Mehla, K., Pipinos, I. I., Powers, R., Yu, F., et al. (2014) · Cancer & Metabolism · doi:10.1186/2049-3002-2-18 · Cited by 255
Self-citationDe Meyer, T., Sinnaeve, D., Van Gasse, B., Tsiporkova, E., Rietzschel, E. R., De Buyzere, M. L., Gillebert, T. C., Bekaert, S., Martins, J. C., & Van Criekinge, W. (2008) · Analytical Chemistry · doi:10.1021/ac7025964 · Cited by 247
Chaika, N. V., Gebregiworgis, T., Lewallen, M. E., Purohit, V., Radhakrishnan, P., Liu, X., Zhang, B., Mehla, K., Brown, R. B., Caffrey, T., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1203339109 · Cited by 227
Self-citationPRIMe: A Web Site That Assembles Tools for Metabolomics and Transcriptomics
Akiyama, K., Chikayama, E., Yuasa, H., Shimada, Y., Tohge, T., Shinozaki, K., Hirai, M. Y., Sakurai, T., Kikuchi, J., & Saito, K. (2008) · In Silico Biology: Journal of Biological Systems Modeling and Multi-Scale Simulation · doi:10.3233/isb-00362 · Cited by 206
Hessmann, E., Patzak, M. S., Klein, L., Chen, N., Kari, V, Ramu, I., Bapiro, T. E., Frese, K. K., Gopinathan, A., Richards, F. M., et al. (2018) · Gut · doi:10.1136/gutjnl-2016-311954 · Cited by 202
Hypoxia Increases Resistance of Human Pancreatic Cancer Cells to Apoptosis Induced by Gemcitabine
Yokoi, K., & Fidler, I. J. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0488 · Cited by 199
Burris, H. A., & Storniolo, A. M. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(96)00324-3 · Cited by 199
Zhao, F., Mancuso, A., Bui, T. V., Tong, X., Gruber, J. J., Swider, C. R., Sanchez, P. V., Lum, J. J., Sayed, N., Melo, J. V., et al. (2010) · Oncogene · doi:10.1038/onc.2010.67 · Cited by 179
Gemcitabine and cisplatin in the treatment of advanced or metastatic pancreatic cancer
Heinemann, V., Wilke, H., Mergenthaler, H.-G., Clemens, M., König, H., Illiger, H. J., Arning, M., Schalhorn, A., Possinger, K., & Fink, U. (2000) · Annals of Oncology · doi:10.1023/a:1026595525977 · Cited by 169
MVAPACK: A Complete Data Handling Package for NMR Metabolomics
Worley, B., & Powers, R. (2014) · ACS Chemical Biology · doi:10.1021/cb4008937 · Cited by 112
Self-citationLin, S., Chien, C., Lee, J., Yeh, Y.-C., Hsu, K., Lai, Y.-Y., Lin, S.-C., & Tsai, S. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44362 · Cited by 107
Chaika, N. V., Yu, F., Purohit, V., Mehla, K., Lazenby, A. J., DiMaio, D. J., Anderson, J. M., Yeh, J. J., Johnson, K. R., Hollingsworth, M. A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032996 · Cited by 102
Self-citationMUC1: A novel metabolic master regulator
Mehla, K., & Singh, P. K. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.01.001 · Cited by 94
Self-citationPhosphorylation of MUC1 by Met Modulates Interaction with p53 and MMP1 Expression
Singh, P. K., Behrens, M. E., Eggers, J. P., Cerny, R. L., Bailey, J. M., Shanmugam, K., Gendler, S. J., Bennett, E., & Hollingsworth, M. A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805036200 · Cited by 90
Self-citationThe reactive tumor microenvironment: MUC1 signaling directly reprograms transcription of CTGF
Behrens, M. E., Grandgenett, P. M., Bailey, J. M., Singh, P. K., Yi, C.-H., Yu, F., & Hollingsworth, M. A. (2010) · Oncogene · doi:10.1038/onc.2010.327 · Cited by 81
Self-citationSchlaepfer, I. R., Glodé, L. M., Hitz, C. A., Pac, C. T., Boyle, K. E., MARONI, P. D., Deep, G., Agarwal, R., Lucia, S. M., Cramer, S. D., et al. (2015) · Molecular Imaging and Biology · doi:10.1007/s11307-014-0814-4 · Cited by 74
Self-citationFanciulli, M., Bruno, T., Giovannelli, A., GENTILE, F., Padova, M. D., Rubiu, O., & Floridi, A. (2000) · PubMed · Cited by 72
Morelli, M. P., Tentler, J. J., Kulikowski, G. N., Tan, A. C., Bradshaw‐Pierce, E. L., Pitts, T. M., Brown, A. M., Nallapareddy, S., Arcaroli, J. J., Serkova, N. J., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1507 · Cited by 46
Self-citationGunda, V., Yu, F., & Singh, P. K. (2016) · PLoS ONE · doi:10.1371/journal.pone.0154416 · Cited by 34
Self-citationLin, J., Zhan, T., Duffy, D., Hoffman-Censits, J. H., Kilpatrick, D. L., Trabulsi, E. J., Lallas, C. D., Chervoneva, I., Limentani, K., Kennedy, B., et al. (2014) · PubMed · Cited by 32
Lin, J., Hoffman-Censits, J. H., Duffy, D., Chervoneva, I., Kilpatrick, D. L., Kennedy, B., Trabulsi, E. J., Lallas, C. D., Gomella, L. G., Force, T. L., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.31.15_suppl.5061 · Cited by 24
Cited by
Role of hypoxia in cancer therapy by regulating the tumor microenvironment
Jing, X., Yang, F., Shao, C., Wei, K., Xie, M., Shen, H., & Shu, Y. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1089-9 · Cited by 2,054
Mitochondrial metabolism and cancer
Porporato, P. E., Filigheddu, N., Pedro, J. M. B.-S., Kroemer, G., & Galluzzi, L. (2018) · Cell Research · doi:10.1038/cr.2017.155 · Cited by 1,273
Glutamine reliance in cell metabolism
Yoo, H. C., Yu, Y. C., Sung, Y., & Han, J. M. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-00504-8 · Cited by 1,021
Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer
Bryant, K. L., Stalnecker, C. A., Zeitouni, D., Klomp, J. E., Peng, S., Tikunov, A. P., Gunda, V., Pierobon, M., Waters, A. M., George, S. D., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0368-8 · Cited by 692
Self-citationMetabolic Regulation of Macrophage Polarization in Cancer
Mehla, K., & Singh, P. K. (2019) · Trends in Cancer · doi:10.1016/j.trecan.2019.10.007 · Cited by 617
Self-citation
Metadata
- Authors
- Shukla, S. K., Purohit, V., Mehla, K., Gunda, V., Chaika, N. V., Vernucci, E., King, R. J., Abrego, J., Goode, G. D., Dasgupta, A., Illies, A. L., Gebregiworgis, T., Dai, B., Augustine, J. J., Murthy, D., Attri, K. S., Mashadova, O., Grandgenett, P. M., Powers, R., Ly, Q. P., Lazenby, A. J., Grem, J. L., Yu, F., Matés, J. M., Asara, J. M., Kim, J.-W., Hankins, J. H., Weekes, C., Hollingsworth, M. A., Serkova, N. J., Sasson, A. R., Fleming, J. B., Oliveto, J. M., Lyssiotis, C. A., Cantley, L. C., Berim, L., & Singh, P. K.
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2017-07
- Volume
- 32
- Issue
- 1
- Pages
- 71-87.e7
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W2735063286
- Cited by
- 540
- References
- 47
- FWCI
- 14.16
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.